top of page
Subscribe
Latest
All News
Reports
Events
Directory
Contact
More
Use tab to navigate through the menu items.
Browse by category
All Posts
All News
Research
Spotlight
Industry & Products
Events & Training
Journal watch
Surgery News
Latest News
Top 10
Search
Altimmune completes dosing in the Phase 2 MOMENTUM trial
Altimmune has completed dosing (last subject last dose) in its 48-week Phase 2 MOMENTUM trial evaluating the efficacy and safety of...
Altimmune begins MOMENTUM obesity trial for Pemvidutide
Altimmune has enrolled the first subject in the 48-week Phase 2 MOMENTUM trial evaluating the safety and efficacy of pemvidutide in...
Browse by tag
obesity
(321)
321 posts
bariatric surgery
(192)
192 posts
type 2 diabetes
(95)
95 posts
weight loss
(82)
82 posts
semaglutide
(61)
61 posts
bariatric and metabolic surgery
(59)
59 posts
SOARD
(47)
47 posts
glucagon-like peptide (GLP-1) analogues
(43)
43 posts
covid-19
(40)
40 posts
Obesity Surgery
(38)
38 posts
Journal watch
(37)
37 posts
diabetes
(34)
34 posts
adolescent obesity
(34)
34 posts
childhood obesity
(33)
33 posts
weight gain
(27)
27 posts
laparoscopic sleeve gastrectomy
(26)
26 posts
product launch
(25)
25 posts
pregnancy
(22)
22 posts
cardiovascular disease
(21)
21 posts
sleeve gastrectomy
(21)
21 posts
Roux-en-Y gastric bypass (RYGB)
(21)
21 posts
First human implant of GLP-1 Implant NPM-115
2 days ago
Roche and Zealand Pharma to co-develop and co-commercialise petrelintide for metabolic diseases
2 days ago
Small intestine APOA4 protein could hold key to obesity treatment
2 days ago
Back to Top
bottom of page